These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6610385)

  • 1. In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.
    Eliopoulos GM; Gardella A; DeGirolami P; Moellering RC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):401-4. PubMed ID: 6610385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Sep; 24(3):375-82. PubMed ID: 6605719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
    Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporin.
    LeFrock JL; Smith BR; Bihl J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):133-7. PubMed ID: 3929676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
    Neu HC; Chin NX; Saha G; Labthavikul P
    Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
    Katsu K; Kitoh K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Aug; 22(2):181-5. PubMed ID: 6100421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ME1228, a new parenteral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1260-7. PubMed ID: 2802554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefepime, a new parenteral cephalosporin, against recent European blood isolates and in comparison with piperacillin/tazobactam.
    Dornbusch K; Mörtsell E; Göransson E
    Chemotherapy; 1990; 36(4):259-67. PubMed ID: 2174761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
    Fung-Tomc J; Dougherty TJ; DeOrio FJ; Simich-Jacobson V; Kessler RE
    Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester.
    Jones RN; Erwin ME; Barrett MS; Briggs BM; Johnson DM
    Diagn Microbiol Infect Dis; 1991; 14(6):473-83. PubMed ID: 1802534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.